The agreement will allow CNN to receive compensation for the use of its intellectual property.

On Thursday, U.S. television network CNN announced an agreement with technology company Google to integrate generative artificial intelligence technologies into its news platforms.

RELATED:

Artificial Intelligence Pioneers Call for International Body to Oversee Cybersecurity Standards

“With this partnership, we are opening new avenues for audiences to access CNN’s exceptional journalism while receiving compensation for the distribution and use of our exclusive intellectual property in connection with AI products,” stated Sam Felix, senior vice president of Strategic Partnerships and Business Development.

The agreement will allow the use of experimental features designed to analyze and enhance audience engagement by exploring new ways to consume and distribute journalistic content.

“Google’s innovation in generative AI has transformed the way people discover information and content, and these tools will now help us explore new ways to be discovered and connect with audiences,” Felix added.

Of course, The Jakarta Globe asked me how I see AI tools influencing newsrooms — both in terms of opportunities and risks.

AI is both enormously helpful and unpredictably dangerous. On the one hand, it significantly accelerates many newsroom processes, from interview… https://t.co/4o871TU8E1 pic.twitter.com/BGDZ2krRro

— Margarita Simonyan (@M_Simonyan) August 12, 2026

The U.S. network explained that its partnership with Google is part of the company’s AI strategy, “which ensures the protection of its intellectual property.”

The agreement is also part of a broader pilot program by the technology company to incorporate its AI technology to drive traffic to media outlets.

“CNN’s deal comes months after it sued Perplexity AI for copyright infringement after both companies failed to reach a licensing deal, its first legal case against an AI company over the unauthorized use of its journalism. At the time, a CNN spokesperson said the network ‘actively embraces the opportunities AI creates,’” Variety recalled.

“It also reflects the impact Google’s AI summaries in its search engine have had on news organizations, many of which have highlighted how the responses have eaten into their web traffic. Penske Media Corporation, the parent company of Variety, The Hollywood Reporter, Rolling Stone and more, sued Google last year over the decline, though a federal judge dismissed the case earlier this month,” it added.

teleSUR/ JF

Sources: EFE – CNN – Variety

An international team of researchers has identified that cabergoline—a drug used to halt the production of breast milk—may reduce the risk of breast cancer when administered at the end of the lactation period. The findings, published this Thursday in the journal Cancer Discovery, combine evidence from animal models with an analysis of the medical records of more than 150,000 women in Spain and Norway.

RELATED:

Science, Women, and Research Beyond Reproduction

The research involved scientists from several countries, including specialists from the Cancer Research Center in Salamanca—a joint facility of the University of Salamanca and the Spanish National Research Council (CSIC).

In studies involving mice, the researchers found that a dose of cabergoline administered at the end of lactation reduced the proportion of animals that developed breast cancer by approximately half. The models used carried mutations in the BRCA1 and TP53 genes, which are linked to DNA repair, the elimination of damaged cells, and aggressive forms of the disease.

According to the team, the drug reduced potentially precancerous tissue, decreased the ductal area, inhibited cell growth, and increased the presence of immune cells involved in defending against tumors.

The study focuses on mammary involution—the natural “clearing” process that occurs after weaning. During pregnancy, hormone levels rise and milk-producing structures branch out; once lactation ends, these cells are no longer needed, and the breast eliminates the excess tissue.

“It’s like a fruit tree; in spring and summer, the breast develops branches and produces flowers and fruit, but when involution occurs—which is the mammary equivalent of winter—the structures required for pregnancy and lactation are reset in preparation for the future,” explained Christopher Maxwell, a professor at the University of British Columbia’s Faculty of Medicine in Canada and a researcher at the BC Children’s Hospital Research Institute.

💊Un fármaco podría reducir el riesgo de #CáncerDeMama postparto

🔬Cabergolina se receta para frenar la lactancia tras el parto

👩‍🔬@ciccancer muestra en ratones que reduce los tumores 

🔎Un ensayo evaluará su eficacia en mujeres tras dejar de amamantar
➡️https://t.co/FqTffmBrvm pic.twitter.com/AahOcNLZyX

— CSIC (@CSIC) October 15, 2026

The text reads, “A drug could reduce the risk of #BreastCancer postpartum. Cabergoline is prescribed to halt breastfeeding after childbirth. @ciccancer shows in mice that it reduces tumors. A trial will evaluate its efficacy in women after stopping breastfeeding”

The researchers discovered that in mice with mutations in the BRCA1 and TP53 genes, this cleanup process can remain incomplete. In such cases, cabergoline appears to help complete the involution process following weaning.

To explore the effect in humans, the team reviewed medical records from Spain and Norway, focusing specifically on young women in the years following pregnancy. In total, the studies included data on the use of cabergoline in more than 150,000 women.

The results showed that women who received the drug to suppress lactation after childbirth—whether due to a medical recommendation, following the loss of a pregnancy, or because breastfeeding was not possible for medical reasons—had an approximately 70 percent lower risk of developing breast cancer compared to those who did not take it.

This association was observed in women under the age of 50 during the years following pregnancy—a period when the risk of this disease can increase.

Cabergoline is a prescription medication used only when medically necessary to stop milk production. It is not currently approved for the prevention of breast cancer; therefore, the authors emphasize that these findings should not be interpreted as a recommendation for its use as a preventive measure.

The next step will be a prospective clinical trial involving women who will receive the drug only after breastfeeding has ended. The goal is to determine whether cabergoline might, in the future, offer a less aggressive alternative to current preventive measures against breast cancer, such as surgery or hormone therapy.

#Science | A new Science special feature is putting the spotlight on major gaps in women’s health research beyond reproduction, from chronic pain and menopause to sex chromosomes and the immune system.

Researchers say significant gaps remain in understanding how diseases affect… pic.twitter.com/NXoaaRa3h5

— teleSUR English (@telesurenglish) October 2, 2026

“We have fallen into habits that are steadily deskilling the human body,” writes Melanie Challenger. “This is a strange turn of events for an animal whose success comes mostly from the extraordinary ability to learn through experience.” For Aeon, Challenger explores how modern technologies, from GPS to AI, are eroding our body’s physical skills by replacing the embodied experiences through which we learn.

After all, the brain is itself a physical organ, continually shaped by what the body does and encounters. Once we decide that the mind is the real human and the rest of the body only hardware, it becomes easier to disregard the physical work, including the neurocognitive work of a biological brain, through which we move, find our way, put thoughts into words, and recognise our own needs. A machine may do some of that work faster, but each act it takes over is one that the body no longer performs and that the body, including the brain, no longer learns through. The irony is that a project motivated by the desire to overcome bodily fragility is helping to produce more fragile bodies.

America’s coming revolution in warfare may not mean fighting fewer wars but fighting more of them without putting Americans on the battlefield. Taking Americans out of the fight When US Defense Secretary Pete Hegseth launched Project Meridian on September 30, he presented it as an exercise in imagining warfare decades into the future. Led by […]

With Washington turning against military aid, a new bilateral framework could take shape based on industrial output and tech integration, but politics will still shape Jerusalem's access to arms

In the final part of our series on the country, Poles tell how wages have soared – along with the cost of living

• Will military spending help or hinder Poland’s growth story?

• Poland’s push for EU energy resilience amid Russian aggression

Above the rain-soaked streets of Warsaw, the observation deck of the Varso tower overlooks Joseph Stalin’s gift to Poland that has divided opinion for decades.

For some, the Soviet-era Palace of Culture and Science is a drunk confectioner’s nightmare; standing as a relic of oppression that should have been demolished. For others, it is an icon on the skyline and a monumental warning from history.

Continue reading...

© Photograph: Anna Liminowicz/The Guardian

© Photograph: Anna Liminowicz/The Guardian

© Photograph: Anna Liminowicz/The Guardian